Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

2/11/22 cb FAQ for Extended-Infusion Dosing
February 16, 2022

From: "Caitlin Bowman" <caitlin.bowman@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Sent: Friday, February 11, 2022 1:31:46 PM
Subject: FAQ for Extended-Infusion Dosing

Good afternoon pharmacists, 
 
AMT has created a new document to help address some frequently asked questions regarding extended infusion dosing (EID). The document includes some common questions or scenarios that might arise in patients receiving our EID antibiotics (meropenem, cefepime, & piperacillin/tazobactam). I have attached the FAQ document to this email and it will also be available shortly on the AMT page on FormWeb (Guidelines > Extended-Infusion > FAQ). Please let AMT know if you have any questions!
 






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved